Literature DB >> 8666891

Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.

T Bevec1, V Stoka, G Pungercic, I Dolenc, V Turk.   

Abstract

The invariant chain (Ii) is associated with major histocompatibility complex class II molecules during early stages of their intracellular transport. In an acidic endosomal/lysosomal compartment, it is proteolytically cleaved and removed from class II heterodimers. Participation of aspartic and cysteine proteases has been observed in in vitro degradation of Ii, but the specific enzymes responsible for its in vivo processing are as yet undefined. We have previously isolated a noncovalent complex of the lysosomal cysteine protease cathepsin L with a peptide fragment derived from the p41 form of Ii from human kidney. Here we show that this Ii fragment, which is identical to the alternatively spliced segment of p41, is a very potent competitive inhibitor of cathepsin L (equilibrium inhibition constant Ki = 1.7 X 10(-12) M). It inhibits two other cysteine proteases, cathepsin H and papain, but to much lesser extent. Cysteine proteases cathepsins B, C, and S, as well as representatives of serine, aspartic, and metalloproteases, are not inhibited at all. These findings suggest a novel role for p41 in the regulation of various proteolytic activities during antigen processing and presentation. The Ii inhibitory fragment shows no sequence homology with the known cysteine protease inhibitors, and may, therefore, represent a new class.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666891      PMCID: PMC2192513          DOI: 10.1084/jem.183.4.1331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture.

Authors:  E Kämpgen; N Koch; F Koch; P Stöger; C Heufler; G Schuler; N Romani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.

Authors:  O Bakke; B Dobberstein
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

4.  Invariant chain influences the immunological recognition of MHC class II molecules.

Authors:  M Peterson; J Miller
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

5.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments.

Authors:  P J Peters; J J Neefjes; V Oorschot; H L Ploegh; H J Geuze
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

6.  Effect of metabolic alterations on the density and the contents of cathepsins B, H and L of lysosomes in rat macrophages.

Authors:  D Muno; N Sutoh; T Watanabe; Y Uchiyama; E Kominami
Journal:  Eur J Biochem       Date:  1990-07-20

7.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

8.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.

Authors:  J J Neefjes; V Stollorz; P J Peters; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

9.  In vivo competition between self peptides and foreign antigens in T-cell activation.

Authors:  L Adorini; S Muller; F Cardinaux; P V Lehmann; F Falcioni; Z A Nagy
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

10.  Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.

Authors:  P A Morton; M L Zacheis; K S Giacoletto; J A Manning; B D Schwartz
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

View more
  36 in total

1.  Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.

Authors:  G Guncar; G Pungercic; I Klemencic; V Turk; D Turk
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

Review 2.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

3.  Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.

Authors:  Valentina Zavasnik-Bergant; Ana Schweiger; Tadeja Bevec; Rastko Golouh; Vito Turk; Janko Kos
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 4.  Protease signalling: the cutting edge.

Authors:  Boris Turk; Dušan Turk; Vito Turk
Journal:  EMBO J       Date:  2012-02-24       Impact factor: 11.598

5.  Potato cysteine proteinase inhibitor gene family: molecular cloning, characterisation and immunocytochemical localisation studies.

Authors:  K Gruden; B Strukelj; M Ravnikar; M Poljsak-Prijatelj; I Mavric; J Brzin; J Pungercar; I Kregar
Journal:  Plant Mol Biol       Date:  1997-05       Impact factor: 4.076

Review 6.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

7.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

8.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.

Authors:  R J Wright; E K Bikoff; B Stockinger
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.